Zenvia (NASDAQ:ZENV – Get Free Report) and Black Titan (NASDAQ:BTTC – Get Free Report) are both small-cap technology companies, but which is the better stock? We will compare the two companies based on the strength of their risk, institutional ownership, analyst recommendations, earnings, dividends, valuation and profitability.
Risk and Volatility
Zenvia has a beta of 1.86, suggesting that its share price is 86% more volatile than the S&P 500. Comparatively, Black Titan has a beta of 1.21, suggesting that its share price is 21% more volatile than the S&P 500.
Valuation & Earnings
This table compares Zenvia and Black Titan”s top-line revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Zenvia | $1.10 billion | 0.02 | -$28.67 million | ($0.40) | -1.17 |
| Black Titan | $2.68 million | 1.77 | -$4.71 million | ($2.95) | -0.11 |
Black Titan has lower revenue, but higher earnings than Zenvia. Zenvia is trading at a lower price-to-earnings ratio than Black Titan, indicating that it is currently the more affordable of the two stocks.
Profitability
This table compares Zenvia and Black Titan’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Zenvia | -10.62% | -14.36% | -6.52% |
| Black Titan | N/A | N/A | N/A |
Insider & Institutional Ownership
49.2% of Zenvia shares are owned by institutional investors. 78.4% of Zenvia shares are owned by company insiders. Comparatively, 53.7% of Black Titan shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.
Analyst Ratings
This is a breakdown of recent ratings and recommmendations for Zenvia and Black Titan, as reported by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Zenvia | 1 | 0 | 0 | 0 | 1.00 |
| Black Titan | 1 | 0 | 0 | 0 | 1.00 |
Summary
Black Titan beats Zenvia on 6 of the 11 factors compared between the two stocks.
About Zenvia
Zenvia is a Brazilian technology company that provides cloud-based customer experience and business communication software. Its platform helps organizations manage interactions with customers across digital channels and automate communications and service workflows. The company’s offerings include messaging and communication tools that support channels such as SMS, WhatsApp, email, voice and web chat, along with software for customer service, marketing campaigns and conversational automation. Businesses can use these tools to coordinate customer interactions throughout the customer lifecycle.
About Black Titan
Titan Pharmaceuticals, Inc. is a biopharmaceutical company developingproprietary therapeutics for the treatment of central nervous system disorders, cancer, and other serious and life threatening diseases. In the central nervous system arena, the company is developing iloperidone, which is clinical testing for schizophrenia through a licensing and development agreement with Novartis Pharma AG. Novartis has tradenamed the product Zomaril.
Receive News & Ratings for Zenvia Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zenvia and related companies with MarketBeat.com's FREE daily email newsletter.
